BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 36961166)

  • 1. Prognostic value of modified-Gustave-Roussy Immunity Score in resectable proximal gastric cancer.
    Shi Y; Ju M; Di X; Sun X; Chen X; He C; Liang L
    Medicine (Baltimore); 2023 Mar; 102(12):e33334. PubMed ID: 36961166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive values of the hemoglobin, albumin, lymphocyte and platelet score (HALP) and the modified -Gustave Roussy immune score for esophageal squamous cell carcinoma patients undergoing concurrent chemoradiotherapy.
    Shi Y; Shen G; Zeng Y; Ju M; Chen X; He C; Liang L; Ge X; Sun X; Di X
    Int Immunopharmacol; 2023 Oct; 123():110773. PubMed ID: 37562292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis of patients with advanced bile tract carcinoma: assessment using the modified-Gustave Roussy Immune Score (mGRIm-s) as a clinico-immunological tool.
    Ma Y; Pan Y; Li Y; Guan H; Dai G
    J Cancer Res Clin Oncol; 2024 May; 150(5):247. PubMed ID: 38722378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gustave Roussy Immune Score based on a three-category risk assessment scale serves as a novel and effective prognostic indicator for surgically resectable early-stage non-small-cell lung cancer: A propensity score matching retrospective cohort study.
    Li SJ; Zhao L; Wang HY; Zhou HN; Ju J; Du H; Che GW
    Int J Surg; 2020 Dec; 84():25-40. PubMed ID: 33086147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective validation of a prognostic score for patients in immunotherapy phase I trials: The Gustave Roussy Immune Score (GRIm-Score).
    Bigot F; Castanon E; Baldini C; Hollebecque A; Carmona A; Postel-Vinay S; Angevin E; Armand JP; Ribrag V; Aspeslagh S; Varga A; Bahleda R; Menis J; Gazzah A; Michot JM; Marabelle A; Soria JC; Massard C
    Eur J Cancer; 2017 Oct; 84():212-218. PubMed ID: 28826074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gustave Roussy Immune Score and Royal Marsden Hospital Prognostic Score Are Biomarkers of Immune-Checkpoint Inhibitor for Non-Small Cell Lung Cancer.
    Minami S; Ihara S; Ikuta S; Komuta K
    World J Oncol; 2019 Apr; 10(2):90-100. PubMed ID: 31068989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gustave Roussy Immune Score as a Novel Prognostic Scoring System for Colorectal Cancer Patients: A Propensity Score Matching Analysis.
    Tian S; Cao Y; Duan Y; Liu Q; Peng P
    Front Oncol; 2021; 11():737283. PubMed ID: 34917499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum parameters as prognostic biomarkers in a real world cancer patient population treated with anti PD-1/PD-L1 therapy.
    Minichsdorfer C; Gleiss A; Aretin MB; Schmidinger M; Fuereder T
    Ann Med; 2022 Dec; 54(1):1339-1349. PubMed ID: 35535695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gustave Roussy Immune Score and Royal Marsden Hospital Prognostic Score Are Prognostic Markers for Extensive Disease of Small Cell Lung Cancer.
    Minami S; Ihara S; Komuta K
    World J Oncol; 2020 Jun; 11(3):98-105. PubMed ID: 32494316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gustave Roussy Immune Score Is a Prognostic Factor for Chemotherapy-Naive Pulmonary Adenocarcinoma With Wild-Type Epidermal Growth Factor Receptor.
    Minami S; Ihara S; Komuta K
    World J Oncol; 2019 Feb; 10(1):55-61. PubMed ID: 30834052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic value of the tumor deposit in N0 gastric cancer by propensity score matching analysis].
    Zhi C; Yang W; Li N; Zhang Z; Hua Y; Liu H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):172-179. PubMed ID: 30799540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of standardized surgical treatment and multidisciplinary treatment strategy on the prognosis of gastric cancer patients: report of a single-center cohort study].
    Zhang WH; Yang K; Chen XZ; Liu K; Chen XL; Zhao LY; Zhang B; Chen ZX; Chen JP; Zhou ZG; Hu JK
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Apr; 23(4):396-404. PubMed ID: 32306609
    [No Abstract]   [Full Text] [Related]  

  • 13. [Value of preoperative abdominal contrast-enhanced multiple-row detector computed tomography in predicting the postoperative 1-year disease-free survival for gastric cancer].
    Feng C; Cheng J; Xiang H; Hong N; Ye Y; Wang Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):1059-1064. PubMed ID: 30269328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Four Clinical Prognostic Scores in Patients with Advanced Gastric and Esophageal Cancer.
    Ma LX; Espin-Garcia O; Bach Y; Aoyama H; Allen MJ; Wang X; Darling GE; Yeung J; Swallow CJ; Brar S; Veit-Haibach P; Kalimuthu S; Wong R; Chen EX; O'Kane GM; Jang RW; Elimova E
    Oncologist; 2023 Mar; 28(3):214-219. PubMed ID: 36378560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of clinicopathological features and prognosis analysis between carcinoma in the remnant stomach and gastric cancer].
    Li F; Wang Y; Li C; Ma Y; Zhang Y; Li Z; Xue Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 May; 21(5):529-534. PubMed ID: 29774934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gustave Roussy Immune Score (GRIm-Score) is a prognostic marker in patients with resectable esophageal squamous cell carcinoma.
    Feng JF; Wang L; Yang X; Chen S
    J Cancer; 2020; 11(6):1334-1340. PubMed ID: 32047540
    [No Abstract]   [Full Text] [Related]  

  • 17. Multicenter Study of Controlling Nutritional Status (CONUT) Score as a Prognostic Factor in Patients With HIV-Related Renal Cell Carcinoma.
    Xue W; Zhang Y; Wang H; Zhang Y; Hu X
    Front Immunol; 2021; 12():778746. PubMed ID: 34917092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term efficacy of robotic radical total gastrectomy for gastric cancer and analysis of prognostic factors].
    Xie SH; Shi Y; Long D; Chen J; Zhao YL; Qian F; Hao YX; Tang B; Li PA; Yu PW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Apr; 23(4):357-363. PubMed ID: 32306603
    [No Abstract]   [Full Text] [Related]  

  • 19. Association of Tumor-Associated Collagen Signature With Prognosis and Adjuvant Chemotherapy Benefits in Patients With Gastric Cancer.
    Chen D; Chen H; Chi L; Fu M; Wang G; Wu Z; Xu S; Sun C; Xu X; Lin L; Cheng J; Jiang W; Dong X; Lu J; Zheng J; Chen G; Li G; Zhuo S; Yan J
    JAMA Netw Open; 2021 Nov; 4(11):e2136388. PubMed ID: 34846524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic factors of lymph node-negative metastasis gastric cancer].
    Sun D; Xu H; Huang J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.